192 related articles for article (PubMed ID: 37570810)
1. Organotin (IV) Dithiocarbamate Compounds as Anticancer Agents: A Review of Syntheses and Cytotoxicity Studies.
Abd Aziz NA; Awang N; Chan KM; Kamaludin NF; Mohamad Anuar NN
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570810
[TBL] [Abstract][Full Text] [Related]
2. Organotin(IV) Dithiocarbamate Complexes: Chemistry and Biological Activity.
Adeyemi JO; Onwudiwe DC
Molecules; 2018 Oct; 23(10):. PubMed ID: 30304779
[TBL] [Abstract][Full Text] [Related]
3. Series of Organotin(IV) Compounds with Different Dithiocarbamate Ligands Induced Cytotoxicity, Apoptosis and Cell Cycle Arrest on Jurkat E6.1, T Acute Lymphoblastic Leukemia Cells.
Rasli NR; Hamid A; Awang N; Kamaludin NF
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110610
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structural characterization and in vitro cytotoxicity of organotin(IV) derivatives of heterocyclic thioamides, 2-mercaptobenzothiazole, 5-chloro-2-mercaptobenzothiazole, 3-methyl-2-mercaptobenzothiazole and 2-mercaptonicotinic acid.
Xanthopoulou MN; Hadjikakou SK; Hadjiliadis N; Schürmann M; Jurkschat K; Michaelides A; Skoulika S; Bakas T; Binolis J; Karkabounas S; Charalabopoulos K
J Inorg Biochem; 2003 Aug; 96(2-3):425-34. PubMed ID: 12888279
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of new Organotin(IV) anticancer agents and their cytotoxicity profile on HL-60, MCF-7 and HeLa human cancer cell lines.
Ullah H; Previtali V; Mihigo HB; Twamley B; Rauf MK; Javed F; Waseem A; Baker RJ; Rozas I
Eur J Med Chem; 2019 Nov; 181():111544. PubMed ID: 31374420
[TBL] [Abstract][Full Text] [Related]
6. Amino acetate functionalized Schiff base organotin(IV) complexes as anticancer drugs: synthesis, structural characterization, and in vitro cytotoxicity studies.
Baul TS; Basu S; de Vos D; Linden A
Invest New Drugs; 2009 Oct; 27(5):419-31. PubMed ID: 18941713
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative and antitumor activity of organotin(IV) compounds. An overview of the last decade and future perspectives.
Banti CN; Hadjikakou SK; Sismanoglu T; Hadjiliadis N
J Inorg Biochem; 2019 May; 194():114-152. PubMed ID: 30851663
[TBL] [Abstract][Full Text] [Related]
8. Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
Sirajuddin M; McKee V; Tariq M; Ali S
Eur J Med Chem; 2018 Jan; 143():1903-1918. PubMed ID: 29133050
[TBL] [Abstract][Full Text] [Related]
9. Potentially bioactive organotin(IV) compounds: synthesis, characterization, in vitro bioactivities and interaction with SS-DNA.
Sirajuddin M; Ali S; McKee V; Sohail M; Pasha H
Eur J Med Chem; 2014 Sep; 84():343-63. PubMed ID: 25036793
[TBL] [Abstract][Full Text] [Related]
10. Recent Advancements in Organotin(IV) Complexes as Potential Anticancer Agents.
Devi J; Yadav J
Anticancer Agents Med Chem; 2018; 18(3):335-353. PubMed ID: 29110624
[TBL] [Abstract][Full Text] [Related]
11. Organotin(IV) complexes derived from Schiff base N'-[(1E)-(2-hydroxy-3-methoxyphenyl)methylidene]pyridine-4-carbohydrazone: synthesis, in vitro cytotoxicities and DNA/BSA interaction.
Hong M; Geng H; Niu M; Wang F; Li D; Liu J; Yin H
Eur J Med Chem; 2014 Oct; 86():550-61. PubMed ID: 25216377
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of the interaction of novel tributyltin(IV) 2/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with an improved cytotoxic profile: synthesis, structure, biological efficacy and QSAR studies.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Pellerito C; Singh P; Verma P; Duthie A; de Vos D; Verma RP; Englert U
J Inorg Biochem; 2010 Sep; 104(9):950-66. PubMed ID: 20553814
[TBL] [Abstract][Full Text] [Related]
13.
Yusof ENM; Latif MAM; Tahir MIM; Sakoff JA; Simone MI; Page AJ; Veerakumarasivam A; Tiekink ERT; Ravoof TBSA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781445
[TBL] [Abstract][Full Text] [Related]
14. Dibutyltin(IV) Complexes Derived from L-DOPA: Synthesis, Molecular Docking, Cytotoxic and Antifungal Activity.
Rocha-Del Castillo E; Gómez-García O; Andrade-Pavón D; Villa-Tanaca L; Ramírez-Apan T; Nieto-Camacho A; Gómez E
Chem Pharm Bull (Tokyo); 2018; 66(12):1104-1113. PubMed ID: 30504627
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and crystal structure of organotin(IV) N-butyl-N-phenyldithiocarbamate compounds and their cytotoxicity in human leukemia cell lines.
Kamaludin NF; Awang N; Baba I; Hamid A; Meng CK
Pak J Biol Sci; 2013 Jan; 16(1):12-21. PubMed ID: 24199481
[TBL] [Abstract][Full Text] [Related]
16. Syntheses, molecular structures, electrochemical behavior, theoretical study, and antitumor activities of organotin(IV) complexes containing 1-(4-chlorophenyl)-1-cyclopentanecarboxylato ligands.
Shang X; Meng X; Alegria EC; Li Q; Guedes da Silva MF; Kuznetsov ML; Pombeiro AJ
Inorg Chem; 2011 Sep; 50(17):8158-67. PubMed ID: 21793560
[TBL] [Abstract][Full Text] [Related]
17. An in vitro comparative assessment with a series of new triphenyltin(IV) 2-/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with anticancer activities: structural modifications, analysis of efficacy and cytotoxicity involving human tumor cell lines.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Duthie A; de Vos D; Verma RP; Englert U
J Inorg Biochem; 2012 Feb; 107(1):119-28. PubMed ID: 22182574
[TBL] [Abstract][Full Text] [Related]
18. New dibutyltin(IV) ladders: Syntheses, structures and, optimization and evaluation of cytotoxic potential employing A375 (melanoma) and HCT116 (colon carcinoma) cell lines in vitro.
Basu Baul TS; Dutta D; Duthie A; Guchhait N; Rocha BGM; Guedes da Silva MFC; Mokhamatam RB; Raviprakash N; Manna SK
J Inorg Biochem; 2017 Jan; 166():34-48. PubMed ID: 27815980
[TBL] [Abstract][Full Text] [Related]
19. Triphenyltin(IV) benzoates with diazenyl/imino scaffold exhibiting remarkable apoptosis mediated by reactive oxygen species.
Basu Baul TS; Dutta D; Duthie A; Prasad R; Rana NK; Koch B; Tiekink ERT
J Inorg Biochem; 2017 Aug; 173():79-92. PubMed ID: 28505480
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic and Luminescent Properties of Novel Organotin Complexes with Chelating Antioxidant Ligand.
Nikitin E; Mironova E; Shpakovsky D; Gracheva Y; Koshelev D; Utochnikova V; Lyssenko K; Oprunenko Y; Yakovlev D; Litvinov R; Seryogina M; Spasov A; Milaeva E
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
